UltraGreen.ai Limited (SGX:UGS)

Market Cap	982.90M
Revenue (ttm)	205.05M +41.2%
Net Income	115.44M +62.5%
EPS	0.12 -99.9%
Shares Out	n/a
PE Ratio	8.51
Forward PE	8.58
Dividend	0.01 (1.41%)
Ex-Dividend Date	Aug 20, 2026

Volume	215,000
Open	0.9050
Previous Close	0.9000
Day's Range	0.9000 - 0.9150
52-Week Range	0.8000 - 1.8400
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About UltraGreen.ai

UltraGreen.ai Limited manufactures and sells Indocyanine Green (ICG) pharmaceutical products in the United States and internationally. It provides diagnostic imaging analytics and software solutions. The company also develops software for real-time quantification of blood perfusion during surgery, including PerfusionWorks quantification software for tissue perfusion, lymphatic mapping, and margin assessment. In addition, it offers products, such as ICG, the IC-Flow Imaging System and the UltraGreen Data Platform and other technologies related t...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2024
• Employees: 112
• Stock Exchange: Singapore Exchange
• Ticker Symbol: UGS

Financial Performance

In 2025, UltraGreen.ai's revenue was $137.94 million, an increase of 27.70% compared to the previous year's $108.02 million. Earnings were $75.63 million, an increase of 35.15%.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 28, 2026

Data Sources Report a data error